NCT07533734Not yet recruiting
The Effects of an Augmented Reality-Based Mirror Therapy System in Patients With Stroke
The Effect of an Augmented Reality-Based Mirror Therapy System on Upper Extremity Motor Recovery and Functional Activity Level in Stroke Patients
Source: ClinicalTrials.gov · Last updated 16 Apr 2026
Brief summary (registry, in English)
Objective The aim of this study is to investigate the effects of an augmented reality-based mirror therapy system (MirrARm), developed using sensor-based tracking and visual feedback principles, on upper extremity motor recovery and functional activity levels in patients with stroke. Research Questions This study seeks to address the following questions: Does the MirrARm system improve upper extremity motor recovery and functional activity levels in patients with stroke? Are the effects of the MirrARm system on upper extremity motor recovery and functional activity levels greater than those of conventional mirror therapy in patients with stroke? Study Design and Comparison The MirrARm system will be compared with conventional mirror therapy to evaluate its effectiveness in patients with stroke. Participants and Procedures Participants will take part in a treatment program administered three days per week for a total duration of eight weeks. Outcome measures will be assessed at baseline (Week 0), at mid-intervention (Week 4), and at the end of the intervention period (Week 8).
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- First submitted
- 9 Apr 2026
- Start date
- 1 Jul 2026
- Primary completion date
- 1 Aug 2027
- Lead sponsor
- Marmara University
- Diseases
- Stroke
- NCT number
- NCT07533734
What you commit to
- Study type: Interventional
- Planned participants: 30
- From 1 Jul 2026 to the primary completion date, 1 Aug 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Presence of neurological, psychiatric, cognitive, or oncological disorders other than stroke.
Other
- Inability to sit independently in a supported chair,
- Insufficient communication ability due to aphasia,
- Presence of structural and/or acquired impairments limiting active movement of the unaffected upper limb,
- Presence of visual or visual-perceptual impairments,
- Presence of unilateral neglect,
Who the study is looking for
- First-ever unilateral stroke diagnosed by a specialist physician,
- Presence of post-stroke hemiplegia,
- Age ≥ 18 years,
- Time since stroke between 3 and 12 months,
- Score ≥ 24 on the Standardized Mini-Mental State Examination,
- Upper extremity motor score ≤ 22 on the Fugl-Meyer Assessment.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Acıbadem University Atakent Hospital Coordinator of this site? Confirm its status | Istanbul | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.